Cardiol Therapeutics Inc. (TSX:CRDL)
Canada · Delayed Price · Currency is CAD 1.620
-0.040 (-2.41%)
Oct 30, 2026, 4:00 PM EDT
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of CAD 189.25 million as of October 30, 2026. It is the 22,901st most valuable company in the world and the 591st biggest in Canada. Its market cap has increased by 43.06% in one year.
Market Cap
189.25M
Enterprise Value
163.28M
Revenue
n/a
Global Rank
Country Rank
#591 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from 94.32M to 189.25M, an increase of 100.66%. That is a compound annual growth rate of 9.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 189.25M | 45.17% |
| Dec 31, 2025 | 130.36M | -13.65% |
| Dec 31, 2024 | 150.97M | 110.34% |
| Dec 29, 2023 | 71.77M | 63.28% |
| Dec 30, 2022 | 43.96M | -69.05% |
| Dec 31, 2021 | 142.02M | 55.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Auxly Cannabis Group | 369.58M |
| Cipher Pharmaceuticals | 343.10M |
| Cresco Labs | 319.03M |
| TerrAscend | 217.97M |
| Cannara Biotech | 199.41M |
| BioSyent | 192.25M |
| Organigram Global | 188.95M |
| Medexus Pharmaceuticals | 155.56M |